A Network-Based Framework to Discover Treatment-Response–Predicting Biomarkers for Complex Diseases
Open Access
- 26 July 2024
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 26 (10) , 917-930
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- The influence of cytokines on the complex pathology of ulcerative colitisAutoimmunity Reviews, 2022
- A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational StudyRheumatology and Therapy, 2021
- A paradigm shift in medicine: A comprehensive review of network-based approachesBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2020
- Dynamic genome and transcriptional network‐based biomarkers and drugs: precision in breast cancer therapyMedicinal Research Reviews, 2018
- MMP3 is a reliable marker for disease activity, radiological monitoring, disease outcome predictability, and therapeutic response in rheumatoid arthritisBest Practice & Research Clinical Rheumatology, 2018
- Understanding the role of cytokines in the pathogenesis of rheumatoid arthritisClinica Chimica Acta, 2016
- Network-Assisted Disease Classification and Biomarker Discovery2016
- The role of cytokines in the pathogenesis of rheumatoid arthritis – Practical and potential application of cytokines as biomarkers and targets of personalized therapyCytokine, 2015
- Mapping RNA‐seq Reads with STARCurrent Protocols in Bioinformatics, 2015
- Up‐regulation of cytokines and chemokines predates the onset of rheumatoid arthritisArthritis & Rheumatism, 2010